TD Private Client Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $86.6K | Buy |
|
|||||
|
2025
Q2 | $56.7K | Sell |
|
|||||
|
2025
Q1 | $80.5K | Sell |
|
|||||
|
2024
Q4 | $122K | Buy |
|
|||||
|
2024
Q3 | $164K | Buy |
|
|||||
|
2024
Q2 | $157K | Sell |
|
|||||
|
2024
Q1 | $151K | Buy |
|
|||||
|
2023
Q4 | $120K | Buy |
|
|||||
|
2023
Q3 | $109K | Sell |
|
|||||
|
2023
Q2 | $97.7K | Sell |
|
|||||
|
2023
Q1 | $120K | Buy |
|
|||||
|
2022
Q4 | $102K | Sell |
|
|||||
|
2022
Q3 | $103K | Buy |
|
|||||
|
2022
Q2 | $68.6K | Sell |
|
|||||
|
2022
Q1 | $110K | Buy |
|
|||||
|
2021
Q4 | $84.6K | Buy |
|
|||||
|
2021
Q3 | $58.1K | Sell |
|
|||||
|
2021
Q2 | $158K | Buy |
|
|||||
|
2021
Q1 | $118K | Buy |
|
|||||
|
2020
Q4 | $80.7K | Sell |
|
|||||
|
2020
Q3 | $115K | Sell |
|
|||||
|
2020
Q2 | $144K | Sell |
|
|||||
|
2020
Q1 | $122K | Buy |
|
|||||
|
2019
Q4 | $37.5K | Buy |
|